Sean Moloughney01.09.09
Consuming St. John’s Wort can help alleviate the symptoms of depression, according to a clinical survey of 200 patients suffering from mild to moderate depression.
The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland, and evaluated several depression factors (e.g., severity, anxiety and nervousness, as well as vegetative [physical/systemic] symptoms).
On average, the study found that six-week, three-times daily consumption of one tablet of St. Johns Wort as A. Vogel Hyperiforce, from Bioforce USA, Ghent, NY, reduced: severity of depression by 54%, anxiety by 49% and nervousness by 50%. Vegetative symptoms also had a high on average reduction rate: gastrointestinal symptoms were decreased by 54%, cardiovascular symptoms (e.g., palpitations) by 58%, sleep disorders by 51%, day fatigue by 57% and headache by 65%.
“This study is quite illuminating and unique because it focuses on the symptoms borne of mild to moderate depression—heart palpitations, sleeplessness, GI problems such as constipation, headache and fatigue,” said Eileen Sheets, managing director of Bioforce USA. “The Bioforce research team felt it was important to reveal how this botanical affects the suite of symptoms typical of mild to moderate depression so that consumers may thus have a clearer understanding of what St. John’s Wort may be able to do for them or their loved ones.”
Study author Feldhaus, summarized: “The treatment with A.Vogel Hyperiforce Tablets during six weeks shows clearly the clinically and statistically significant reduction of symptoms of depression but also of concomitant vegetative symptoms. We feel this is an excellent rating of efficacy and tolerability by patients in the study.”
The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland, and evaluated several depression factors (e.g., severity, anxiety and nervousness, as well as vegetative [physical/systemic] symptoms).
On average, the study found that six-week, three-times daily consumption of one tablet of St. Johns Wort as A. Vogel Hyperiforce, from Bioforce USA, Ghent, NY, reduced: severity of depression by 54%, anxiety by 49% and nervousness by 50%. Vegetative symptoms also had a high on average reduction rate: gastrointestinal symptoms were decreased by 54%, cardiovascular symptoms (e.g., palpitations) by 58%, sleep disorders by 51%, day fatigue by 57% and headache by 65%.
“This study is quite illuminating and unique because it focuses on the symptoms borne of mild to moderate depression—heart palpitations, sleeplessness, GI problems such as constipation, headache and fatigue,” said Eileen Sheets, managing director of Bioforce USA. “The Bioforce research team felt it was important to reveal how this botanical affects the suite of symptoms typical of mild to moderate depression so that consumers may thus have a clearer understanding of what St. John’s Wort may be able to do for them or their loved ones.”
Study author Feldhaus, summarized: “The treatment with A.Vogel Hyperiforce Tablets during six weeks shows clearly the clinically and statistically significant reduction of symptoms of depression but also of concomitant vegetative symptoms. We feel this is an excellent rating of efficacy and tolerability by patients in the study.”